TAPI-2 – 1 mg

Brand:
Cayman
CAS:
187034-31-7
Storage:
-20
UN-No:
Non-Hazardous - /

The extracellular domains of many different types of transmembrane proteins, including growth factors, growth factor receptors and cell adhesion molecules, are proteolytically released (shed) in response to environmental cues. TNF protease inhibitor 2 (TAPI-2) is a broad-spectrum inhibitor of TNF-α converting enzyme (TACE), other ADAMs (a disintegrin and metalloproteinases), and other matrix metalloproteinases. It inhibits phorbol-12-myristate-13-acetate-induced (PMA) shedding of various cell surface proteins, such as TGF-α, β amyloid precursor protein, L-selectin, and IL-6 receptor α subunit, with an IC50 value of 10 µM.{23493} TAPI-2 inhibits ADAM8, 10, 12, and TACE with Ki values of 10, 3, 100, and 0.12 µM, respectively.{23492} In T4-2 breast cancer cells, 20 µM TAPI-2 prevented mobilization of the growth factors TGF-α and amphiregulin leading to reversion of the malignant cellular phenotype.{23494}  

 

SKU: - Category:

Description

A broad-spectrum inhibitor of TACE, other ADAMs, and other MMPs; inhibits PMA-induced shedding of various cell surface proteins, such as TGF-α, βAPP, L-selectin, IL-6 receptor α subunit (IC50 = 10 µM); prevents mobilization of the growth factors TGF-α and amphiregulin in culture leading to reversion of malignant breast cancer cell phenotype


Formal name: N-[2-[2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide

Synonyms:  TNF Protease Inhibitor 2

Molecular weight: 415.5

CAS: 187034-31-7

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Cancer||Research Area|Cell Biology|Proteolysis|Cytosolic & Secreted Proteases